Logo image of VYNT

VYANT BIO INC (VYNT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:VYNT - US92942V2088 - Common Stock

0.26 USD
-0.08 (-23.51%)
Last: 5/12/2023, 8:07:00 PM
0.2211 USD
-0.04 (-14.96%)
After Hours: 5/12/2023, 8:07:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VYNT. VYNT was compared to 525 industry peers in the Biotechnology industry. Both the profitability and financial health of VYNT have multiple concerns. VYNT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year VYNT has reported negative net income.
  • In the past year VYNT has reported a negative cash flow from operations.
VYNT Yearly Net Income VS EBIT VS OCF VS FCFVYNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M

1.2 Ratios

  • VYNT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VYNT Yearly ROA, ROE, ROICVYNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -50 -100 -150 -200 -250

1.3 Margins

  • VYNT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VYNT Yearly Profit, Operating, Gross MarginsVYNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -1K -2K -3K

3

2. Health

2.1 Basic Checks

  • VYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VYNT has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, VYNT has a worse debt to assets ratio.
VYNT Yearly Shares OutstandingVYNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M 5M
VYNT Yearly Total Debt VS Total AssetsVYNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of -11.95, we must say that VYNT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -11.95, VYNT is not doing good in the industry: 80.35% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.03 indicates that VYNT is not too dependend on debt financing.
  • VYNT has a Debt to Equity ratio (0.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -11.95
ROIC/WACCN/A
WACC8.02%
VYNT Yearly LT Debt VS Equity VS FCFVYNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 3.14 indicates that VYNT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.14, VYNT is doing worse than 69.89% of the companies in the same industry.
  • VYNT has a Quick Ratio of 3.13. This indicates that VYNT is financially healthy and has no problem in meeting its short term obligations.
  • VYNT has a worse Quick ratio (3.13) than 68.94% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 3.13
VYNT Yearly Current Assets VS Current LiabilitesVYNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

1

3. Growth

3.1 Past

  • VYNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.61%.
  • Looking at the last year, VYNT shows a very negative growth in Revenue. The Revenue has decreased by -86.19% in the last year.
  • Measured over the past years, VYNT shows a very negative growth in Revenue. The Revenue has been decreasing by -53.03% on average per year.
EPS 1Y (TTM)-101.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-260.59%
Revenue 1Y (TTM)-86.19%
Revenue growth 3Y-55%
Revenue growth 5Y-53.03%
Sales Q2Q%-95.99%

3.2 Future

  • Based on estimates for the next years, VYNT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.54% on average per year.
  • VYNT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -41.42% yearly.
EPS Next Y37.93%
EPS Next 2Y19.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VYNT Yearly Revenue VS EstimatesVYNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
VYNT Yearly EPS VS EstimatesVYNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VYNT. In the last year negative earnings were reported.
  • Also next year VYNT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VYNT Price Earnings VS Forward Price EarningsVYNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VYNT Per share dataVYNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VYNT's earnings are expected to grow with 19.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • VYNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VYANT BIO INC / VYNT FAQ

What is the ChartMill fundamental rating of VYANT BIO INC (VYNT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to VYNT.


What is the valuation status of VYANT BIO INC (VYNT) stock?

ChartMill assigns a valuation rating of 3 / 10 to VYANT BIO INC (VYNT). This can be considered as Overvalued.


How profitable is VYANT BIO INC (VYNT) stock?

VYANT BIO INC (VYNT) has a profitability rating of 0 / 10.


Can you provide the financial health for VYNT stock?

The financial health rating of VYANT BIO INC (VYNT) is 2 / 10.


What is the expected EPS growth for VYANT BIO INC (VYNT) stock?

The Earnings per Share (EPS) of VYANT BIO INC (VYNT) is expected to grow by 37.93% in the next year.